James A. Merritt
President chez Kalos Therapeutics, Inc.
Profil
James A.
Merritt is currently the Director at Project Concern International, Director at San Diego Opera, and President & Chief Medical Officer at Kalos Therapeutics, Inc. He was previously the Chief Executive Officer at Imagine Pharmaceuticals, Inc. from 2003 to 2006, Chief Medical Officer at Introgen Therapeutics, Inc. from 1996 to 2003, and Chief Medical Officer at Mast Therapeutics, Inc. in 2008.
He also worked as a Principal at Chiron Viagene, Inc. and IDEC Pharmaceuticals Corp.
Dr. Merritt received his undergraduate degree from The Johns Hopkins University and his doctorate from the University of Vermont.
Postes actifs de James A. Merritt
| Sociétés | Poste | Début |
|---|---|---|
Kalos Therapeutics, Inc.
 Kalos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kalos Therapeutics, Inc. provides biopharmaceutical product development services. The company develops and commercializes products for the treatment of cancers and related co-morbidities. The company was founded by George Colberg and is headquartered in Phoenix, AZ. | President | - |
San Diego Opera
 San Diego Opera Movies/EntertainmentConsumer Services San Diego Opera engages in vocal performances and operatic arts. It offers education and community engagement services. The company was founded in 1965 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Project Concern International
 Project Concern International Miscellaneous Commercial ServicesCommercial Services Project Concern International engages in proviison of health and poverty reduction programs. It offers health and poverty solutions worldwide by preventing disease, responding to the HIV/AIDS crisis, combating world hunger and malnutrition, improving child survival and maternal child health, delivering lifesaving immunizations, and offering humanitarian assistance. The company was founded by Jim Turpin in 1961 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de James A. Merritt
| Sociétés | Poste | Fin |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 29/01/2008 |
Imagine Pharmaceuticals, Inc.
 Imagine Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Imagine Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops small molecules that enable the delivery of cancer therapeutics to meta-static and primary brain tumors. The company is headquartered in San Diego, CA. | President | 01/01/2006 |
| INTROGEN THERPUT | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Corporate Officer/Principal | - |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de James A. Merritt
| The Johns Hopkins University | Undergraduate Degree |
| University of Vermont | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Introgen Therapeutics, Inc.
 Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Chiron Viagene, Inc.
Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Commercial Services |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Imagine Pharmaceuticals, Inc.
Imagine Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Imagine Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops small molecules that enable the delivery of cancer therapeutics to meta-static and primary brain tumors. The company is headquartered in San Diego, CA. | Retail Trade |
Project Concern International
Project Concern International Miscellaneous Commercial ServicesCommercial Services Project Concern International engages in proviison of health and poverty reduction programs. It offers health and poverty solutions worldwide by preventing disease, responding to the HIV/AIDS crisis, combating world hunger and malnutrition, improving child survival and maternal child health, delivering lifesaving immunizations, and offering humanitarian assistance. The company was founded by Jim Turpin in 1961 and is headquartered in San Diego, CA. | Commercial Services |
San Diego Opera
San Diego Opera Movies/EntertainmentConsumer Services San Diego Opera engages in vocal performances and operatic arts. It offers education and community engagement services. The company was founded in 1965 and is headquartered in San Diego, CA. | Consumer Services |
Kalos Therapeutics, Inc.
Kalos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kalos Therapeutics, Inc. provides biopharmaceutical product development services. The company develops and commercializes products for the treatment of cancers and related co-morbidities. The company was founded by George Colberg and is headquartered in Phoenix, AZ. | Health Technology |
